Taiwan News1d
Junshi Biosciences Announces 2024 Full Year Financial Results and Provides Corporate Updates
In June 2024, Junshi Biosciences convened the 2023 annual general meeting, the 2024 first class meeting of A shareholders and the 2024 first class meeting of H shareholders, and completed the election ...
Bristol Myers announces CHMP recommendation for Opdivo formulation approval
Bristol Myers (BMY) announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has recommended approval ...
STAT2d
At meeting on guardrails for gene editing of human embryos, some call for a dead end
At meeting on human embryo editing, CRISPR pioneer says science is a long way from knowing if germline DNA can be safely ...
Testing for just three genes could help prevent 75% of avoidable side effects for certain medications
A new study from Queen Mary University of London found that 9% of all reported adverse drug reactions (ADRs) reported to the ...
Pharmaceutical Technology3d
How bioconjugation is unlocking the next generation of drug development
Bioconjugation presents an new frontier for pharmaceutical development, providing an option for improved drug efficacy across ...